Vascular surgery using argatroban in a patient with a history of heparin-induced thrombocytopenia

Circulation Journal

Volumn 67, Issue 10, 2003, Pages 889-890

  Tokuda, Yoshiyuki ^a   Matsumoto, Masahiko ^a   Sugita, Takaaki ^a   Nishizawa, Junichiro ^a   Matsuyama, Katsuhiko ^a   Yoshida, Kazunori ^a   Matsuo, Takehiko ^a  

^a TENRI HOSPITAL   (Japan)

Author keywords

Argatroban; Heparin induced thrombocytopenia; Vascular surgery

Indexed keywords

ANTICOAGULANT AGENT; ARGATROBAN; DANAPAROID; HEPARIN; LEPIRUDIN; NAFAMSTAT MESILATE; RECOMBINANT HIRUDIN;

AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CASE REPORT; DRUG CONTRAINDICATION; DRUG INDUCED DISEASE; DRUG MONITORING; HEART SURGERY; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; THROMBOCYTOPENIA; VASCULAR SURGERY;

AGED; ANTICOAGULANTS; CARDIOVASCULAR SURGICAL PROCEDURES; HEPARIN; HUMANS; MALE; PERIOPERATIVE CARE; PERIPHERAL VASCULAR DISEASES; PIPECOLIC ACIDS; THROMBOCYTOPENIA;

EID: 0141960979     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.67.889     Document Type: Article

References (10)

1. Warkentin TE. Heparin-induced thrombocytopenia: A clinicopathologic syndrome. Thromb Haemost 1999; 82: 439-447.
2. Ohteki H, Furukawa K, Ohnishi H, Narita Y, Sakai M, Doi K. Clinical experience of Argatroban for anticoagulation in cardiovascular surgery. Jpn J Thorac Cardiovasc Surg 2000; 48: 39-46.
3. Greinacher A, Volpel H, Janssens U, Hach-Wunderle V, Kemkes-Matthes B, Eichler P, et al. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: A prospective study. Circulation 1999; 99: 73-80.
4. Koster A, Pasic M, Bauer M, Kuppe H, Hetzer R. Hirudin as anti-coagulant for cardiopulmonary bypass: Importance of preoperative renal function. Ann Thorac Surg 2000; 69: 37-41.
5. Wilhelm MJ, Schmid C, Kececioglu D, Mollhoff T, Ostermann H, Scheld HH. Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia using Org 10172. Ann Thorac Surg 1996; 61: 920-924.
6. Vun CH, Evans S, Chong BH. Cross-reactivity study of low molecular weight heparins and heparinoid in heparin-induced thrombocytopenia. Thromb Res 1996; 81: 525-532.
7. Potzsch B, Klovekom WP, Madlener K. Use of heparin during cardiopulmonary bypass in patients with a history of heparin-induced thrombocytopenia. N Engl J Med 2000; 343: 515.
8. Amiral J, Bridey F, Wolf M, Boyer-Neumann C, Fressinaud E, Vissac AM, et al. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: A study of 44 cases. Thromb Haemost 1995; 73: 21-28.
9. Swan SK, Hursting MJ. The pharmacokinetics and pharmacodynamics of argatroban: Effects of age, gender, and hepatic or renal dysfunction. Pharmacotherapy 2000; 20: 318-329.
10. Lewis BE, Wallis DE, Berkowitz SD, Matthai WH, Fareed J, Walenga JM, et al. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation 2001; 103: 1838-1843.